Anagennis Costa Rica · Residential intensive
Measured before.
Measured after.
Every other clinic in this category sells regenerative therapy on mechanism — a diagram of a cell and a paragraph about signalling. We sell it on measurement.
You arrive with a complete physiological and biomarker baseline from the Canadian assessment. You receive the intervention under supervision. You are re-measured against that baseline, on the same instruments, by the same protocols. Nobody who does not own the assessment engine can offer you that comparison.
Tier 1
Established, evidence-supported
Delivered at a dose and duration outpatient care cannot reach.
Extended hyperbaric oxygen therapy
Established for defined indicationsHard-shell multiplace chamber, protocolised sessions at therapeutic pressure up to 2.0 ATA, in courses of 20 to 40 sessions. This is the dose that outpatient delivery cannot practically provide — the reason it is residential is arithmetic, not atmosphere.
Structured residential fasting and fasting-mimicking
Evidence-supportedFive to ten days, medically supervised, with daily biochemistry and daily physician review. Refeeding is part of the protocol, not an afterthought.
Intensive physiology reconditioning
EstablishedTwice-daily supervised training with continuous monitoring, and direct measurement of adaptation on the same instruments used at your Canadian baseline.
Advanced hormonal management
Varies by agent — stated per prescriptionA wider formulary under Costa Rican prescribing authority, including compounded preparations and growth hormone secretagogues, initiated under supervision with defined monitoring.
Comprehensive imaging as a programme component
Established as structural imagingIncluding whole-body MRI where you elect it, read within the same dataset as everything else.
Tier 2
The regenerative programme
Each service carries a named written consent document, a stated evidence tier, a defined protocol and a monitoring plan. You will read and sign the consent before anything is scheduled.
Exosome / extracellular vesicle therapy
InvestigationalWe disclose source tissue, characterisation method, particle count and route of administration on the consent document before you decide. Clinics that will not publish their sourcing are asking you to buy a word.
Therapeutic plasma exchange
Established for defined haematological and neurological indications; investigational for healthspan indicationsApheresis-based removal and replacement of plasma volume. The consent and the protocol state the circuit, the number of sessions, the replacement fluid and the monitoring plan. We keep the two evidence statuses separate, because blurring them is how this therapy gets oversold. This is not young-plasma transfusion, which we do not offer.
Autologous mesenchymal stem cell therapy
InvestigationalAdipose- or marrow-derived, expanded under the site's cell-therapy licence, with the expansion protocol and release criteria disclosed.
Allogeneic perinatal MSC therapy
InvestigationalSourced only from a licensed, traceable tissue facility, with the standard that facility is held to named on the consent document.
Peptide therapy
InvestigationalThymosin alpha-1, BPC-157, CJC-1295/ipamorelin, GHK-Cu, epitalon — each with its own consent document and dosing protocol.
Senolytic protocols
InvestigationalDasatinib with quercetin, or fisetin, on intermittent monitored dosing.
Off-label longevity pharmacology
Off-label, evidence varies by agentRapamycin on intermittent dosing, acarbose, metformin, low-dose naltrexone, 17α-estradiol.
High-dose intravenous therapy
Varies by agentVitamin C, glutathione, alpha-lipoic acid and NAD⁺, with G6PD screening and cardiac monitoring where indicated.
Ozone therapy / major autohaemotherapy
InvestigationalOffered with its evidence status stated plainly rather than implied.
EDTA chelation
Established for confirmed heavy-metal burden onlyOffered only on documented unprovoked testing. We do not use provoked challenge testing, which generates positive results by design.
Advanced imaging and genomics
EstablishedWhole-body MRI is included in residential programmes; whole-genome sequencing is available with genetic counselling attached.
What we do not offer
Published because the omissions describe the clinic as accurately as the menu does.
- Fetal or embryonic stem cell products
- Young-plasma transfusion — distinct from therapeutic plasma exchange, and frequently confused with it
- Any oncology treatment or cancer-cure claim, in either jurisdiction
- Gene therapy — follistatin, klotho, telomerase. This is a research programme with its own governance, not a purchasable item on a clinic website
- Thermography, live-blood and dark-field microscopy, bioenergetic and bioresonance testing
- Provoked heavy-metal challenge testing
- Multi-cancer early detection blood panels
- Any therapy sold on a stated lifespan-extension claim
Request a consult
Discuss Costa Rica residential programme with a physician
Choose the clinic and the dates that suit you. Every course begins with an assessment, and we will tell you plainly if this is not the right intervention for you.
Interventions restricted under Canadian regulation are delivered at our Costa Rica clinic, under the same physicians and the same protocol.